As ER stress is an attractive target to treat skeletal dysplasias including EDM5, we, therefore, used our established luciferase screening assay to determine if these “natural” chemicals were able to reduce pathological ER stress in cells expressing the archetypal V194D matrilin-3 vWFA mutation. Here, MATN3 is linked to skeletal dysplasia.